<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01426217</url>
  </required_header>
  <id_info>
    <org_study_id>22743</org_study_id>
    <nct_id>NCT01426217</nct_id>
  </id_info>
  <brief_title>Reduction in IV Associated Contamination</brief_title>
  <official_title>Reduction in Intraoperative Lumen Contamination of Standard 3-Way Open Lumen Stopcock Sets Through Use of a Novel, Passive Bundle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PSI Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether implementing a novel syringe and IV
      stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination
      and infections in patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bacterial contamination of patient intravenous stopcock sets is a common intraoperative event
      associated with increased patient mortality, possibly via an infectious mechanism. The most
      common type of intravenous tubing used in operating rooms is the open lumen stopcock set
      which lacks a barrier between the environment and intraluminal space, and thus the
      intravascular space of the patient. The stopcock connector can be easily contaminated by
      provider hands due to improper handling of the device and/or contaminated by soiled syringe
      tips subsequently connected to the device. Further, the stopcock connector is often left
      uncapped by the provider and directly exposed to the environment. Thus, common breaches in
      intraoperative aseptic practice of healthcare providers can lead to bacterial contamination
      of the endoluminal space of the open lumen device. The primary aim of the current study is to
      assess the efficacy of a passive bundle designed to decrease intravenous stopcock and tubing
      intraluminal bacterial contamination. This passive bundle includes two novel interventions, a
      DOCit station and HubScrub caps. The HubScrub is designed to clean the needleless connectors
      and open lumen stopcock systems. The DOCit station is designed to simultaneously clean the
      interior and exterior of needle-less luer connectors of syringes with isopropyl alcohol while
      also providing a method of storage and organization of multiple syringes. The investigators
      hypothesize that the application of this passive bundle to the standard open lumen system
      commonly employed by anesthesia providers in the operating room will significantly reduce
      bacterial contamination of standard 3-way open lumen stopcock sets and improve patient
      safety.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of Bacterial IV Stopcock Lumen Contamination</measure>
    <time_frame>48 hours</time_frame>
    <description>The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination</measure>
    <time_frame>Until positive, up to 5 days</time_frame>
    <description>Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port. BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria. Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive. Once positive, the liquid in the bottle was examined to identify the organism.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">594</enrollment>
  <condition>Post-operative Infections</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control arm using standard of care operating room procedures and equipment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Problem Solving Innovations (PSI) Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implementation of the passive bundle including HubScrub and DocIt</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt</intervention_name>
    <description>Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.</description>
    <arm_group_label>Problem Solving Innovations (PSI) Experimental</arm_group_label>
    <other_name>PSI Medical HubScrub</other_name>
    <other_name>PSI Medical DocIt</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient undergoing surgery or procedure in operating room

          -  Undergoing general anesthesia

        Exclusion Criteria:

          -  Children (age &lt; 18 years)

          -  Lack of intravenous access

          -  failure of anesthesia provider to complete training on experimental device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan S Brindeiro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Randy W Loftus, MD</last_name>
    <role>Study Director</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Loftus RW, Muffly MK, Brown JR, Beach ML, Koff MD, Corwin HL, Surgenor SD, Kirkland KB, Yeager MP. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg. 2011 Jan;112(1):98-105. doi: 10.1213/ANE.0b013e3181e7ce18. Epub 2010 Aug 4.</citation>
    <PMID>20686007</PMID>
  </reference>
  <reference>
    <citation>Koff MD, Loftus RW, Burchman CC, Schwartzman JD, Read ME, Henry ES, Beach ML. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a novel device. Anesthesiology. 2009 May;110(5):978-85. doi: 10.1097/ALN.0b013e3181a06ec3.</citation>
    <PMID>19352154</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Koff MD, Burchman CC, Schwartzman JD, Thorum V, Read ME, Wood TA, Beach ML. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008 Sep;109(3):399-407. doi: 10.1097/ALN.0b013e318182c855.</citation>
    <PMID>18719437</PMID>
  </reference>
  <results_reference>
    <citation>Loftus RW, Brindeiro BS, Kispert DP, Patel HM, Koff MD, Jensen JT, Dodds TM, Yeager MP, Ruoff KL, Gallagher JD, Beach ML, Brown JR. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg. 2012 Dec;115(6):1315-23. doi: 10.1213/ANE.0b013e31826d2aa4. Epub 2012 Nov 9.</citation>
    <PMID>23144441</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 29, 2011</study_first_submitted>
  <study_first_submitted_qc>August 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2011</study_first_posted>
  <results_first_submitted>August 20, 2018</results_first_submitted>
  <results_first_submitted_qc>September 20, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2018</results_first_posted>
  <last_update_submitted>September 20, 2018</last_update_submitted>
  <last_update_submitted_qc>September 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IV contamination</keyword>
  <keyword>intravenous contamination</keyword>
  <keyword>stopcock contamination</keyword>
  <keyword>surgical site infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted over 3-month period (Aug 1, 2011 to Nov 8, 2011) at Dartmouth-Hitchcock Medical Center, a tertiary care and level 1 trauma center in New Hampshire with 400 inpatient beds and 28 operating suites. The operating rooms enrolled during the study period were randomly selected on a daily basis from the available 28 operating rooms</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Control arm using standard of care operating room procedures and equipment.</description>
        </group>
        <group group_id="P2">
          <title>Experimental Group</title>
          <description>Implementation of passive bundle which includes HubScrub and DOCIt device into the operating room environment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="314"/>
                <participants group_id="P2" count="280"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="306"/>
                <participants group_id="P2" count="266"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>lost sample</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Control arm using standard of care operating room procedures and equipment</description>
        </group>
        <group group_id="B2">
          <title>Experimental Group</title>
          <description>Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="306"/>
            <count group_id="B2" value="266"/>
            <count group_id="B3" value="572"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.7" spread="16.3"/>
                    <measurement group_id="B2" value="57.5" spread="15.7"/>
                    <measurement group_id="B3" value="57.6" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="304"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="306"/>
                    <measurement group_id="B2" value="266"/>
                    <measurement group_id="B3" value="572"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Presence of Bacterial IV Stopcock Lumen Contamination</title>
        <description>The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control arm using standard of care operating room procedures and equipment</description>
          </group>
          <group group_id="O2">
            <title>PSI Experimental</title>
            <description>Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.
Problem Solving Innovations (PSI) Passive Bundle: PSI Medical HubScrub, PSI Medical DocIt</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Bacterial IV Stopcock Lumen Contamination</title>
          <description>The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed</description>
          <units>percent stopcock contamination rate</units>
          <param>Number</param>
          <units_analyzed>Operating Rooms</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="306"/>
                <count group_id="O2" value="266"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Operating Rooms</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="306"/>
                <count group_id="O2" value="266"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Efficacy</non_inferiority_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination</title>
        <description>Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port. BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria. Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive. Once positive, the liquid in the bottle was examined to identify the organism.</description>
        <time_frame>Until positive, up to 5 days</time_frame>
        <population>Specific data for each arm can not be obtained. Sincere efforts were made to obtain and report the data, however, no data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Population</title>
            <description>Experimental and Control groups were combined for analysis.
Control arm used standard of care operating room procedures and equipment.
Experimental arm implemented a of passive bundle which includes HubScrub and DocIt device into the operating room environment.</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination</title>
          <description>Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port. BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria. Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive. Once positive, the liquid in the bottle was examined to identify the organism.</description>
          <population>Specific data for each arm can not be obtained. Sincere efforts were made to obtain and report the data, however, no data is available.</population>
          <units>cases of effluent contamination</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="572"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Efficacy</non_inferiority_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>1.35</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <desc>Experimental &amp; Control groups were combined for analysis. Sincere efforts were made to gather &amp; report data, however, no specific data for each group is available.
Events:
Presence of elevated white blood cells count, fever, anti-infection meds order, office visit/inpatient progress note noting signs of infection &amp;/or bacterial cultures; Positive for ≥1 evaluated if HealthCare Associated Infection
Clinical diagnosis of IV catheter–associated phlebitis</desc>
      <group_list>
        <group group_id="E1">
          <title>Entire Population</title>
          <description>Experimental and Control groups were combined for analysis.
Control arm used standard of care operating room procedures and equipment.
Experimental arm implemented a of passive bundle which includes HubScrub and DocIt device into the operating room environment.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="572"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="572"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="572"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>HCAI</sub_title>
                <description>Healthcare associated infections (HCAI)</description>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="572"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="572"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Randy Loftus, MD</name_or_title>
      <organization>Dartmouth-Hitchcock Medical Center</organization>
      <phone>(603) 650-6177</phone>
      <email>Randy.W.Loftus@hitchcock.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

